ST
KERX

Spot Trading’s Keryx Biopharmaceuticals Inc KERX Stock Holding History

Spot Trading’s Portfolio KERX Stock Details KERX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-19,646
Closed -$115K – 3518
2016
Q4 		$115K Buy
19,646
+1,603
+9% +$8.76K ﹤0.01% 2158
2016
Q3 		$96K Sell
18,043
-47,300
-72% -$255K ﹤0.01% 2420
2016
Q2 		$433K Sell
65,343
-14,179
-18% -$79.3K 0.01% 1721
2016
Q1 		$371K Buy
+79,522
New +$317K 0.01% 1799
2015
Q3 		– Sell
-43,042
Closed -$430K – 4460
2015
Q2 		$430K Buy
+43,042
New +$462K ﹤0.01% 2222
2014
Q4 		– Sell
-10,743
Closed -$148K – 4604
2014
Q3 		$148K Sell
10,743
-67,936
-86% -$1.04M ﹤0.01% 3337
2014
Q2 		$1.21M Buy
78,679
+67,639
+613% +$959K 0.01% 1999
2014
Q1 		$188K Sell
11,040
-235,548
-96% -$3.55M ﹤0.01% 3166
2013
Q4 		$3.19M Buy
246,588
+122,664
+99% +$1.46M 0.02% 1208
2013
Q3 		$1.25M Sell
123,924
-104,755
-46% -$932K 0.01% 1728
2013
Q2 		$1.71M Buy
+228,679
New +$1.79M 0.01% 1503

Other funds holding KERX

BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return
CLM
ClearBridge LLC (Maryland) Baltimore, Maryland $329M AUM 9.73% 1-Year Est. Return

Spot Trading's KERX Position: Q1 2017 in Review

Spot Trading sold out of Keryx Biopharmaceuticals Inc (KERX) in Q1 2017, closing a stake of 19,646 shares — an estimated $115K sold.

Spot Trading first reported a position in KERX in Q2 2013 and held it in 11 quarters. The position peaked at $3.19M in Q4 2013. 119 funds tracked by Wall St. Rank hold KERX as of Q1 2017.

  • Spot Trading reported no remaining Keryx Biopharmaceuticals Inc position as of Q1 2017 after selling out during the quarter.
  • Spot Trading sold 19,646 Keryx Biopharmaceuticals Inc shares in Q1 2017, an estimated $115K.
  • Spot Trading first reported a position in Keryx Biopharmaceuticals Inc in Q2 2013 and held it in 11 quarters.
  • Spot Trading's Keryx Biopharmaceuticals Inc position peaked at $3.19M in Q4 2013.
  • 119 funds tracked by Wall St. Rank held Keryx Biopharmaceuticals Inc as of Q1 2017.

Based on Spot Trading's 13F filing for Q1 2017, filed 1 May 2017.